IHH Healthcare Q4 gain up 28%, excluding exceptional items

Singapore

MAINBOARD-listed IHH Healthcare's fourth-quarter underlying net profit was boosted by proactive cost tightening measures and better operational efficiency.

Chief executive officer and managing director Kelvin Loh said on Friday that the group is on track to doubling the firm's return on equity (ROE) over five years from 2020 to 2024, with most of it driven by organic growth. In 2019, the group's ROE stood at 2.5 per cent.